Osteoclasts, blasts, and cytes Flashcards

1
Q

The cell in bone that is responsible for resorbing (removing) bone. It is a multinucleated cell of hematopoietic origin (macrophage/monocyte lineage)

A

Osteoclast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The cell in bone that is responsible for forming new bone. It is of mesenchymal origin

A

Osteoblast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The cell that is embedded in the mineralized bone matrix. It is derived from an osteoblast which has become entrapped in the mineralized bone.

A

Osteocyte

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

the process by which mature/damaged bone is removed by osteoclasts and replaced with new bone (i.e. bone is replaced but there is no net gain)

A

Bone remodeling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

the process by which bone size/shape is changed by independent actions of osteoblasts and osteoclasts (e.g. adding new bone without prior resorption or removing bone without replacing it). Can occur during longitudinal growth of bone or in response to an increase in mechanical loading of the bone. Modeling can lead to a net gain or loss of bone.

A

Bone modeling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

A disease of impaired mineralization due to mutations in the gene for alkaline phosphatase (TNSALP) that results in reduced amounts or no alkaline phosphatase.

A

Hypophosphatasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

A disease due to mutations in the RUNX2 gene. Patients have partly or completely missing clavicles and supernumerary teeth.

A

Cleidocranial Dysplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

(A.k.a. “Stone man syndrome”) – a disease in which there is ectopic mineralization in non-skeletal soft tissues, leading to sheets, plates of bones forming across the ribs, joints, etc. This restricts the movement of the skeleton. The disease is due to mutations in the BMP type I receptor (ACVR1) that make it hyperresponsive to BMP ligands.

A

Fibrodysplasia Ossificans Progressiva

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

These are diseases due to mutations in the gene for sclerostin (SOST). Reduced amounts of sclerostin lead to increased bone mass.

A

Sclerostosis and Van Buchem’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

a disease of impaired osteoclast function that leads to bones that are abnormally dense but brittle and prone to fracture. The disorder is caused by mutations in genes important for osteoclast resorption.

A

Osteopetrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

a disease of low bone mass that occurs due to the inability of bone formation to keep up with bone resorption (i.e. not all the bone that is resorbed is replaced, so there is a net loss in bone mass). Usually seen in post-menopausal women and/or the aged population (male and female).

A

Osteoporosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

a drug that inhibits bone resorption

A

Anti-resorptive agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

a drug that stimulates bone formation

A

Bone anabolic agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

a fancy word for bone that forms in the wrong place

A

Heterotopic bone formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

a fancy word for a cell that can sense mechanical (deformation) input

A

Mechanosensor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

a fancy word for bone that is dead and does not have viable osteocytes

A

Osteonecrotic bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Osteoblasts, chondrocytes, myoblasts, and adipocytes differentiate from a __________ precursor

A

common mesenchymal precursor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

_____ produces large amounts of ECM proteins (mainly collagen type 1) which then mineralizes (osteoid); the lifespa is weeks

A

osteoblasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

RUNX2 and Osterix seen in osteoblasts are ____

A

transcription factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Alkaline phosphatase seen in osteoblasts are

A

enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Type 1 collagen, osteopontin, osteocalcin, and bone sialoprotein seen in osteoblasts are

A

ECM proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

___ is a master TF for bone; essential bone and tooth development; heterozygous mutation of _____ in humans results in cleidocranial dysplasia (CCD)

A

RUNX2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

_____ is autosomal dominant mutation characterized by haploinsufficiency of RUNX2; clavicles partly or completely missing, supernumerary teeth, prognathic mandible due to hypoplasia of maxilla

A

Cleidocranial dysplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

____ is a key transcription factor for osteoblast differentiation that is downstream of RUNX2; critical for osteoblast differentiation; controls expression of osteoblast genes (type 1 collagen, osteocalcin, and osteopontin)

A

Osterix

25
Q

___ and ___ are key signaling pathways that regulate osteoblast differentiation

A

BMPs and WNT / Beta-catenin

26
Q

____ is originally purified from bone extracts that induce bone formation when implanted in muscle; required for skeletal development / maintenance of adult bone homeostasis, promote differentiation from early osteoprogenitor cells, important in fracture healing; mutations result in inherited skeletal disorders in humans

A

Bone morphogenetic proteins (BMP)

27
Q

___ is a heterotopic bone formation resulting in ribbons, sheets, or plates of bone in extraskeletal sites; bone forms in response to tissue trauma; mutations in BMP type 1 receptor that causes mild constitutive activation

A

Fibrodysplasia ossificans progressiva (FOP)

28
Q

____ signaling pathway is important in determining bone mass

A

WNT B-catenin

29
Q

High and Low Bone mass phenotypes are due to mutations in _____

A

LRP5

30
Q

Enzyme highly expressed in osteoblasts/odontoblasts, hydrolyzes pyrophosphate (natural inhibitor of mineralized, thereby increasing local phosphate concentration) which promotes mineralization; mutations are associated with hypophosphatasia

A

alkaline phosphatase

31
Q

rare heritable rickets/osteomalacia; mutations in human alkaline phosphatase gene (TNSLAP); characterized by reduced activity of alkaline phosphatase, impaired mineralization of skeleton, leg bowing, rachitic rosary, early tooth loss, waddling gait, muscle weakness, seizures; vary severity from perinatal lethal to adult onset or mild forms only affecting dentition (dependent on degree of loss of function of alkaline phosphatase)

A

hypophosphatasia

32
Q

terminally differentiated osteoblasts embedded in bone matrix that make up over 90% of all bone cells with long dendritic processes; active cell type; lifespan is decades

A

osteocytes

33
Q

Mef2c in osteocytes is a _____

A

transcription factor

34
Q

E11/gp38/podoplanin, Dentin matrix protein-1 (DMP1), matrix extracellular phosphoglycoprotein (MEPE), and phosphate regulating endopeptidase homolog, X- linked in osteocytes are ____

A

early osteocyte markers

35
Q

Sclerostin in osteocytes is a _____

A

late osteocyte marker

36
Q

Mechanosensors that control responses of bone cells to mechanical loading, control of bone resorption and bone formation regulating osteoclasts and blasts, regulate mineralization, and regulators of mineral homeostasis are potential functions of _____

A

osteocytes

37
Q

____ is highly expressed in mature osteocytes, cementocytes, and odontoblasts, negative regulator of bone formation that antagonizes Wnt/B catenin signaling, thought to act as brake to limit bone formation

A

Sclerostin

38
Q

Deletion or mutation of SOST (sclerostin) results in _______ characterized by increased bone mass especially obvious in craniofacial skeleton and antibodies to to sclerostin

A

Sclerosteosis (Van Buren’s disease)

39
Q

____ establishes the osteocytes as a key target cell for development of new treatments for diseases of bone loss and overgrowth

A

sclerostin

40
Q

____ express several genes important in phosphate homeostasis including FGF23, DMP1, and PHEX

A

Osteocytes

41
Q

____ are derived from same precursors as macrophages, when mature are multinucleated, express proteases for removing ECM proteins, express proteins that act as proton pumps to generate H+ that reduce pH to dissolve material; have specialized ruffled border to increase surface area in resorption compartment; lifespan is short (days)

A

osteoclasts

42
Q

____ is responsible for bone resorption during normal bone growth and remodeling, removal of alveolar bone during tooth eruption, resorption of tooth roots of primary teeth, removal of alveolar bone during orthodontic tooth movement, and bone loss in pathological condition

A

osteoclasts

43
Q

What is the master transcription factor of osteoclasts?

A

NFATc1

44
Q

____ and _____ are downstream of NFATc1 and important in osteoclast formation

A

C-Fos and NFkB

45
Q

___ promotes proliferation and survival of osteoclast precursors

A

M-CSF

46
Q

_____ ( member of TNF superfamily) is required for osteoclast fusion and differentiation

A

RANKL

47
Q

___ is a natural inhibitor of RANKL

A

OPG

48
Q

_____ needs to differentiate/fuse, adhere to the bone surface, produce acid to dissolve material, produce proteases to breakdown ECM protein, and respond to factors that regulate osteoclast survival/activity

A

osteoclast

49
Q

Osteoclasts attach via _____ integrins to form sealed zone

A

avB3

50
Q

In a mature resorbing osteoclast, ____ generates protons

A

Carbonic anhydrase 2

51
Q

In a mature resorbing osteoclast, Vacuolar type H+ ATPase pumps protons into _____ that creates acid pH

A

resorption lacuna

52
Q

In a mature resorbing osteoclast, ____ and ___ exchanger on basolateral surface removes excess bicarbonate

A

Cl and HCO3

53
Q

In a mature resorbing osteoclast, ___ maintains neutrality

A

Chloride channel

54
Q

In a mature resorbing osteoclast, ______ also released into resorption lacuna to digest matrix proteins

A

Cathepsin K

55
Q

___ can be due to failure in osteoclast formation or function; bones are abnormally dense and prone to fracture, failed osteoclastic resorption affects bone growth remodeling and tooth eruption; can be accompanied by scoliosis, nerve compression in head and face, impaired marrow function, enlarged liver or spleen, dental abnormalities, short stature, slow growth, and recurrent infetions

A

Osteopetrosis

56
Q

a patient with Bone mineral density of > 2.5 standard deviations below average for a healthy young female or male.

A

Osteoporosis

57
Q
  • Amino bisphosphonates
  • Hormone replacement therapy
  • Selective Estrogen Receptor Modulators (SERMs)
A

Anti-resorptives that are current treatments for osteoporosis.

58
Q

(1) current or previous treatment with a bisphosphonate
(2) exposed, necrotic bone in the maxillofacial region that has been present for at least 8 weeks
(3) no history of radiation therapy to the jaws

thought to be caused by suppression
of bone turnover due to Bisphosphinate inhibition of osteoclast activity

A

Bisphosphonate Associated Osteonecrosis of the Jaw (BONJ)